Abstract
Denielli da Silva Gonçalves Bos, Chris Happé, Ingrid Schalij, Wioletta Pijacka, Christophe Guignabert, Ly Tu, Raphaël Thuillet, Harm-Jan Bogaard, Albert C. van Rossum, Anton Vonk-Noordegraaf, Frances S. de Man, M. Louis Handoko
Abstract
Authors
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Perspectives on novel therapeutic strategies for right heart failure in pulmonary arterial hypertension: lessons from the left heart
10.1183/09059180.00007109 · 2010
Pressure-overload-induced right heart failure
2014
Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?
10.1164/rccm.201209-1663pp · 2013
Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension
10.1164/rccm.201203-0411oc · 2012
Emerging concepts in the molecular basis of pulmonary arterial hypertension: part II: neurohormonal signaling contributes to the pulmonary vascular and right ventricular pathophenotype of pulmonary arterial hypertension
10.1161/circulationaha.114.006980 · 2015
The role of the renin-angiotensin-aldosterone system in the pathobiology of pulmonary arterial hypertension (2013 Grover Conference series)
10.1086/675984 · 2014
Increased sympathetic nerve activity in pulmonary artery hypertension
10.1161/01.cir.0000140724.90898.d3 · 2004
Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension
10.1183/09031936.00145708 · 2009
Prognostic significance of sympathetic nervous system activation in pulmonary arterial hypertension
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1164/rccm.200912-1856oc · 2010
Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study
10.1093/eurjhf/hfs173 · 2013
Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension
10.1002/1096-9896(2000)9999:9999<::aid-path715>3.0.co;2-q · 2000
Adrenergic receptor blockade reverses right heart remodeling and dysfunction in pulmonary hypertensive rats
10.1164/rccm.201003-0335oc · 2010
Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension
10.1161/circheartfailure.111.964494 · 2012
Nebivolol for improving endothelial dysfunction, pulmonary vascular remodeling, and right heart function in pulmonary hypertension
10.1016/j.jacc.2014.11.050 · 2015
Non-pharmacological modulation of the autonomic tone to treat heart failure
10.1093/eurheartj/eht436 · 2014
Renal denervation for the treatment of cardiovascular high risk-hypertension or beyond?
10.1161/circresaha.115.302522 · 2014
Renal sympathetic denervation: applications in hypertension and beyond
10.1038/nrcardio.2013.89 · 2013
Renal denervation in heart failure
10.1007/s11906-014-0528-7 · 2015
Functional role of renal afferents
10.1152/physrev.1991.71.3.659 · 1991
Sympathetic modulation of renal hemodynamics, renin release and sodium excretion
10.1007/bf01717340 · 1989
Physiology in perspective: the Wisdom of the Body. Neural control of the kidney
10.1152/ajpregu.00258.2005 · 2005
Opposite effects of training in rats with stable and progressive pulmonary hypertension
10.1161/circulationaha.108.829713 · 2009
SuHx rat model: partly reversible pulmonary hypertension and progressive intima obstruction
10.1183/09031936.00204813 · 2014
Translational examination of changes in baroreflex function after renal denervation in hypertensive rats and humans
10.1161/hypertensionaha.113.01261 · 2013
Single-beat estimation of right ventricular end-systolic pressure-volume relationship
10.1152/ajpheart.01023.2002 · 2003
Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio
10.1161/01.res.32.3.314 · 1973
Rapid quantification of myocardial fibrosis: a new macro-based automated analysis
10.1007/s13402-011-0035-7 · 2011
Effects of exercise training in patients with idiopathic pulmonary arterial hypertension
10.1183/09031936.00027909 · 2009
Right ventricular diastolic impairment in patients with pulmonary arterial hypertension
10.1161/circulationaha.113.001873 · 2013
Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension
10.1007/s00392-015-0930-4 · 2015
Effect of percutaneous renal sympathetic nerve radiofrequency ablation in patients with severe heart failure
2015
Beneficial effects of renal denervation on pulmonary vascular remodeling in experimental pulmonary artery hypertension
10.1016/j.recesp.2014.11.025 · 2015
Catheter-based renal denervation as a treatment for pulmonary hypertension: hope or hype?
10.1016/j.recesp.2015.03.011 · 2015
Improvements in left ventricular hypertrophy and diastolic function following renal denervation: effects beyond blood pressure and heart rate reduction
10.1016/j.jacc.2013.10.073 · 2014
Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension
10.1016/j.jacc.2011.11.034 · 2012
Effects of multielectrode renal denervation on cardiac and neurohumoral adaptations in resistant hypertension with cardiac hypertrophy: an EnligHTN I substudy
10.1097/hjh.0000000000000408 · 2015
Renal denervation mitigates cardiac remodeling and renal damage in Dahl rats: a comparison with beta-receptor blockade
10.1038/hr.2015.133 · 2015
Renal sympathetic denervation improves cardiac dysfunction in rats with chronic pressure overload
10.33549/physiolres.932912 · 2015
Diastolic pressure-volume quotient (DPVQ) as a novel echocardiographic index for estimation of LV stiffness in HFpEF
10.1007/s00392-015-0863-y · 2015
Right ventricular myocardial stiffness in experimental pulmonary arterial hypertension: relative contribution of fibrosis and myofibril stiffness
10.1161/circheartfailure.115.002636 · 2016
Mineralocorticoid receptor antagonism attenuates experimental pulmonary hypertension
10.1152/ajplung.00300.2012 · doi-reference
Aldosterone inactivates the endothelin-B receptor via a cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide levels and modulate pulmonary arterial hypertension
10.1161/circulationaha.112.094722 · doi-reference